Effects of p21ciP1/waf1 overexpression on growth, apoptosis and differentiation in human colon carcinoma cells

International Journal of Oncology

Volumn 27, Issue 1, 2005, Pages 69-76

  Izawa, Hikaru ^a   Yamamoto, Hirofumi ^a   Damdinsuren, Bazarragchaa ^a   Ikeda, Kimimasa ^a   Tsujie, Masaki ^a   Suzuki, Rei ^a   Kitani, Kotaro ^a   Seki, Yosuke ^a   Hayashi, Taro ^a   Takemasa, Ichiro ^a   Ikeda, Masataka ^a   Ohue, Masayuki ^a   Sekimoto, Mitsugu ^a   Monden, Takushi ^a   Monden, Morito ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adenomatous polyps; Apoptosis; Cell growth; Colorectal cancer; Differentiation; Gene therapy; p21; p53

Indexed keywords

AGAR; ALKALINE PHOSPHATASE; BUTYRIC ACID DERIVATIVE; CDKN1A PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; FLUOROURACIL; ISOBUTYRIC ACID; PROTEIN P53;

APOPTOSIS; ARTICLE; CARCINOMA; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMISTRY; COLON TUMOR; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMAN; IC 50; METABOLISM; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; TIME; TUMOR CELL LINE; WESTERN BLOTTING;

AGAR; ALKALINE PHOSPHATASE; APOPTOSIS; BLOTTING, WESTERN; BUTYRIC ACIDS; CARCINOMA; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA MUTATIONAL ANALYSIS; FLOW CYTOMETRY; FLUOROURACIL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITORY CONCENTRATION 50; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 24644524555     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.27.1.69     Document Type: Article

References (49)

1. Hunter T and Pines J: Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 79: 573-582, 1994.
2. Macleod KF, Sherry N, Hannon G, Beach D, Tokino T, Kinzler K, Vogelstein B and Jacks T: p53-dependent and independent expression of p21 during cell growth, differentiation and DNA damage. Genes Dev 9: 935-944, 1995.
3. Sherr CJ and Roberts JM: Inhibitors of mammalian Gl cyclindependent kinases. Genes Dev 9: 1149-1163, 1995.
4. Polyak K, Hamilton SR, Vogelstein B and Kinzler KW: Early alterations of cell-cycle-regulated gene expression in colorectal neoplasia. Am J Pathol 149: 381-387, 1996.
5. Doglioni C, Pelosio P, Laurino L, Macri E, Meggiolaro E, Favretti F and Barbareschi M: p21/WAFl/CIPl expression in normal mucosa and in adenomas and adenocarcinomas of the colon: its relationship with differentiation. J Pathol 179: 248-253, 1996.
6. Shiohara M, El-Deiry WS, Wada M, Nakamaki T, Takeuchi S, Yang R, Chen DL, Vogelstein B and Koeffler HP: Absence of WAF1 mutations in a variety of human malignancies. Blood 84: 3781-3784,1994.
7. Matsushita K, Kobayashi S, Kato M, Itoh Y, Okuyama K, Sakiyama S and Isono K: Reduced messenger RNA expression level of p21CIPl in human colorectal carcinoma tissues and its association with p53 gene mutation. Int J Cancer 69: 259-264, 1996.
8. Sheikh MS, Rochefort H and Garcia M: Overexpression of p21WAFl/CIPl induces growth arrest, giant cell formation and apoptosis in human breast carcinoma cell lines. Oncogene 11 : 1899-1905, 1995.
9. Li WW, Fan JG, Hochhauser D and Bertino JR: Overexpression of p21(wafl) leads to increased inhibition of E2F-1 phosphorylation and sensitivity to anticancer drugs in retinoblastoma-negative human sarcoma cells. Cancer Res 57: 2193-2199, 1997.
10. Hsiao M, Tse V, Carmel J, Costanzi E, Strauss B, Haas M and Silverberg GD: Functional expression of human p21(WAFl/CIPl) gene in rat glioma cells suppresses tumor growth in vivo and induces radiosensitivity. Biochem Biophys Res Commun 233: 329-335, 1997.
11. Wang J and Walsh K: Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science 273: 359-361, 1996.
12. Gorospe M, Wang X, Guyton KZ and Holbrook NJ: Protective role of p21 (Waf 1/Cipl) against prostaglandin A2-mediated apoptosis of human colorectal carcinoma cells. Mol Cell Biol 16:6654-6660, 1996.
13. Attardi LD, Lowe SW, Brugarolas J and Jacks T: Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-medialed apoptosis. EMBO J 15: 3693-3701,1996.
14. Kobayashi T, Consoli U, Andreeff M, Shiku H, Deisseroth AB and Zhang W: Activation of p21WAFl/Cipl expression by a temperature-sensitive mutant of human p53 does not lead to apoptosis. Oncogene 11: 2311-2316, 1995.
15. Steinman RA, Hoffman B, I ro A, Guillouf C, Liebermann DA and EI-Houseini ME: Induction of p21 (WAF-1/CIPl) during differentiation. Oncogene 9: 3389-3396, 1994.
16. Guo K, Wang J, Andres V, Smith RC and Walsh K: MyoDinduced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol Cell Biol 15:3823-3829, 1995.
17. Schwaller J, Koeffler HP, Niklaus G, Loetscher P, Nagel S, Fey MF and Tobler A: Posttranscriptional stabilization underlies p53-independent induction of p21 WAF1/CIP1/ SDH in differentiating human leukemic cells. J Clin Invest 95: 973-979, 1995.
18. Poluha W, Poluha DK, Chang B, Crosbie NE, Schonhoff CM, Kilpatrick DL and Ross AH: The cyclin-dependent kinase inhibitor p21 (WAF1) is required for survival of differentiating neuroblastoma cells. Mol Cell Biol 16: 1335-1341, 1996.
19. Yoshida K, Murohashi I and Hirashima K: p53-independent induction of p21(WAFl/CIPl) during differentiation of HL-60 cells by tumor necrosis factor alpha. Int J Hematol 65: 41-48, 1996.
20. Gartel AL, Serfas MS, Gartel M, Goufman E, Wu GS, El-Deiry WS and Tyner AL: p21 (WAF1/CIP1) expression is induced in newly non-dividing cells in diverse epithelia and during differentiation of the Caco-2 intestinal cell line. Exp Cell Res 227: 171-181, 1996.
21. Evers BM, Ko TC, Li J and Thompson EA: Cell cycle protein suppression and p21 induction in differentiating Caco-2 cells. Am J Physiol 271 : G722-G777, 1996.
22. Siavoshian S, Blottiere HM, Cherbut C and Galmiche JP: Butyrate stimulates cyclin D and p21 and inhibits cyclin-dependent kinase 2 expression in HT29 colonic epithelial cells. Biochem Biophys Res Commun 232: 169-172, 1997.
23. Ohue M, Tomita N, Monden T, et al: A frequent alteration of p53 gene in carcinoma in adenoma of colon. Cancer Res 54: 4798-4804, 1994.
24. Yamamoto H, Kondo M, Nakamori S, Nagano H, Wakasa K, Sugita Y, Chang-De J, Kobayashi S, Damdinsuren B, Dono K, Umeshita K, Sekimoto M, Sakon M, Matsuura N and Monden M: JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis. Gastroenterology 125: 556-571, 2003.
25. Basson MD, Turowski GA, Rashid Z, Hong F and Madri JA: Regulation of human colonic cell line proliferation and phenotype by sodium butyrate. Dig Dis Sci 41: 1989-1993, 1996.
26. Doki Y, Imoto M, Han EK, Sgambato A and Weinstein IB: Increased expression of the P27KIP1 protein in human esophageal cancer cell lines that over-express cyclin Dl. Carcinogenesis 18: 1139-1148,1997.
27. Hague A, Elder DJ, Hicks DJ and Paraskeva C: Apoptosis in colorectal tumor cells: induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate. Int J Cancer 60: 400-406, 1995.
28. Yasui W, Akama Y, Yokozaki H, Semba S, Kudo Y, Shimamoto F and Tahara E: Expression of p21WAFl/CIPl in colorectal adenomas and adenocarcinomas and its correlation with p53 protein expression. Pathol Int 47: 470-477, 1997.
29. Gomyo Y, Ikeda M, Osaki M, Tatebe S, Tsujitani S, Ikeguchi M, Kaibara N and Ito H: Expression of p21 (wafl/cipl/sdil), but not p53 protein, is a factor in the survival of patients with advanced gastric carcinoma. Cancer 79: 2067-2072, 1997.
30. Dergham ST, Dugan MC, Joshi US, Chen YC, Du W, Smith DW, Arlauskas P, Crissman JD, Vaitkevicius VK and Sarkar FH: The clinical significance of p21(WAFl/CIP-l) and p53 expression in pancreatic adenocarcinoma. Cancer 80: 372-381, 1997.
31. Galizia G, Lieto E, Ferraraccio F, Orditura M, De Vita F, Castellano P, Imperatore V, Romano C, Ciardiello F, Agostini B and Pignatelli C: Determination of molecular marker expression can predict clinical outcome in colon carcinomas. Clin Cancer Res 10:3490-3499,2004.
32. Yang ZY, Perkins ND, Ohno T, Nabel EG and Nabel GJ: The p21 cyclin-dependent kinase inhibitor suppresses tumorigenicity in vivo. Nat Med 1: 1052-1056, 1995.
33. Chen J, Willingham T, Shuford M, Bruce D, Rushing E, Smith Y and Nisen PD: Effects of ectopic overexpression of p21(WAFl/CIPl) on aneuploidy and the malignant phenotype of human brain tumor cells. Oncogene 13: 1395-1403, 1996.
34. Eastham JA, Hall SJ, Sehgal I, et at In vivo gene therapy with p53 or p21 adenovirus for prostate cancer. Cancer Res 55: 5151-5155, 1995.
35. Yokoyama Y, Takahashi Y, Morishita S, Hashimoto M and Tamaya T: Introduction of p21(Wafl/Cipl) gene into a carcinoma cell line of the uterine cervix with inactivated p53. Cancer Lett 116: 233-239, 1997.
36. Kano A, Watanabe Y, Takeda N, Aizawa S and Akaike T: Analysis of IFN-gamma-induced cell cycle arrest and cell death in hepatocytes. J Biochem (Tokyo) 121: 677-683, 1997.
37. Torres K and Horwitz SB: Mechanisms of Taxol-induced cell death are concentration dependent. Cancer Res 58: 3620-3626, 1998.
38. Sheikh MS, Garcia M, Zhan Q, Liu Y and Fornace AJ Jr: Cell cycle-independent regulation of p21Wafl/Cipl and retinoblastoma protein during okadaic acid-induced apoptosis is coupled with induction of Bax protein in human breast carcinoma cells. Cell Growth Differ 7: 1599-1607, 1996.
39. Chen G, Shu J and Stacey DW: Oncogenic transformation potentiates apoptosis, S-phase arrest and stress-kinase activation by etoposide. Oncogene 15: 1643-1651, 1997.
40. Gorospe M, Liu Y, Xu Q, Chrest FJ and Holbrook NJ: Inhibition of Gl cyclin-dependent kinase activity during growth arrest of human breast carcinoma cells by prostaglandin A2. Mol Cell Biol 16: 762-770, 1996.
41. McDonald ER III, Wu GS, Waldman T and El-Deiry WS: Repair defect in p21 WAF1/CIP1 -/- human cancer cells. Cancer Res 56: 2250-2255, 1996.
42. Waldman T, Lengauer C, Kinzler KW and Vogelstein B: Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 381: 713-716, 1996.
43. Sheikh MS, Chen YQ, Smith ML and Fornace AJ Jr: Role of p21Wafl/Cipl/Sdil in cell death and DNA repair as studied using a tetracycline-inducible system in p53-deficient cells. Oncogene 14: 1875-1882, 1997.
44. Freemerman AJ, Vrana JA, Tombes RM, Jiang H, Chellappan SP, Fisher PB and Grant S: Effects of antisense p21 (WAF1/CIP1/MDA6) expression on the induction of differentiation and drugmediated apoptosis in human myeloid leukemia cells (HL-60). Leukemia 11:504-513, 1997.
45. Missero C, Di Cunto F, Kiyokawa H, Koff A and Dotto GP: The absence of p21Cipl/WAFl alters keratinocyte growth and differentiation and promotes ras-tumor progression. Genes Dev 10:3065-3075,1996.
46. Liu M, Lee MH, Cohen M, Bommakanti M and Freedman LP: Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 10: 142-153, 1996.
47. Matsumura I, Ishikawa J, Nakajima K, Oritani K, Tomiyama Y, Miyagawa J, Kato T, Miyazaki H, Matsuzawa Y and Kanakura Y: Thrombopoietin-induced differentiation of a human megakaryoblastic leukemia cell line, CMK, involves transcriptional activation of p21(WAFl/Cipl) by STAT5. Mol Cell Biol 17: 2933-2943, 1997.
48. Di Cunto F, Topley G, Calautti E, Hsiao J, Ong L, Seth PK and Dotto GP: Inhibitory function of p21Cipl/WAFl in differentiation of primary mouse keratinocytes independent of cell cycle control. Science 280: 1069-1072, 1998.
49. King KL, Hwang JJ, Chau GY, Tsay SH, Chi CW, Lee TG, Wu LH, Wu CW and Lui WY: Ki-67 expression as a prognostic marker in patients with hepatocellular carcinoma. J Gastroenterol Hepatol 13: 273-279, 1998.